Julie Prettyman, RN, BSN, CCRCAdvanceMed Research, Lawrenceville, NJ
Onset and Maintenance of Testosterone Suppression in 4 Pivotal Trials of Subcutaneously Administered Leuprolide Acetate Formulated with Biodegradable Polymer Delivery System
Julie Prettyman, RN, BSN, CCRC, John A. McLane, PhD, Stuart N. Atkinson, MB, ChB, Allison Tyler, RN, BSN, OCN, CCRP, Deborah M. Boldt-Houle, PhD
November 9, 2018 | November 2018 Vol 9, NO 11
In prostate cancer therapy, achieving and maintaining effective testosterone (T) suppression to the level attained with surgical castration is the cornerstone of androgen deprivation therapy (ADT).
Last modified: December 19, 2018